Some studies in severe COVID-19 patients have revealed that an early TGF-β production is associated with the impairment of immune cells such as NK cells and B cells (Ferreira-Gomes and others 2021; Witkowski and others 2021), which contributes to a failure of the host early viral clearance. This evidence concerns the gene TGFB1 and COVID-19.